Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 69Unknown 15Terminated 14Withdrawn 6Recruiting 6Active not recruiting 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 82Breast Neoplasms 38Lung Neoplasms 26Triple Negative Breast Neoplasms 25Ovarian Neoplasms 20Squamous Cell Carcinoma of Head and Neck 19Fallopian Tube Neoplasms 16Small Cell Lung Carcinoma 15Neoplasm Metastasis 13Esophageal Neoplasms 12Endometrial Neoplasms 12Prostatic Neoplasms 9Neoplasms 9Head and Neck Neoplasms 8Colorectal Neoplasms 8Carcinoma 8Urinary Bladder Neoplasms 7Uterine Cervical Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Oropharyngeal Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Pancreatic Neoplasms 5Melanoma 5Laryngeal Neoplasms 5Carcinoma, Transitional Cell 5Stomach Neoplasms 4Mouth Neoplasms 4Carcinoma, Squamous Cell 4Carcinoma, Ovarian Epithelial 4Urothelial Cancer 3

Interventions

pembrolizumab 5Paclitaxel 5Carboplatin 4Cisplatin 3Bevacizumab 3oregovomab 2Nivolumab 2Hyperthermic Intraperitoneal Chemotherapy 2tislelizumab 1spartalizumab 1rucaparib 1olaparib 1niraparib 1lenvatinib 1fludarabine phosphate 1fludarabine 1anlotinib 1Taxes 1Surveys and Questionnaires 1Saline Solution 1Ramucirumab 1Platinum 1Nutrition Assessment 1Neoadjuvant Therapy 1Leucovorin 1Irinotecan 1Immunotherapy, Adoptive 1Glucose 1Gemcitabine 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Ovarian Epithelial × Carboplatin × Clear all
NCT03393884 2026-05-04

OVATION 2

Imunon

Phase 1/2 Active not recruiting
130 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT04498117 2026-04-01

FLORA-5

CanariaBio Inc.

Phase 3 Active not recruiting
615 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT03872947 2025-08-03

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Toray Industries, Inc

Phase 1 Active not recruiting
138 enrolled
DermatologicGastrointestinalGenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Melanoma, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT02124421 2024-11-19

CRS/HIPEC

Mercy Medical Center

Phase 2 Active not recruiting
32 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡